Biotech · Private company · Chicago, IL, US
Enzyme By Design, Inc.
Track this companyFree. Adds Enzyme By Design, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Validating the reduced immunogenicity of novel human-like asparaginases to de-risk clinical developmentFiscal year 2026 · $400KNIH RePORTER 1R43CA306391-01A1 · fetched Nov 12, 2026
- Engineering in vivo half-life extension of a novel mammalian asparaginase to increase feasibility of pan-cancer therapyFiscal year 2024 · $400KNIH RePORTER 1R43CA291296-01 · fetched Nov 12, 2026